The Cooper Companies, Inc. (NASDAQ:COO) Short Interest Up 8.1% in November

The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report) was the recipient of a significant growth in short interest during the month of November. As of November 30th, there was short interest totalling 2,390,000 shares, a growth of 8.1% from the November 15th total of 2,210,000 shares. Based on an average daily volume of 1,240,000 shares, the short-interest ratio is presently 1.9 days.

Insiders Place Their Bets

In related news, CEO Albert G. White III sold 114,992 shares of the firm's stock in a transaction that occurred on Thursday, September 19th. The shares were sold at an average price of $110.53, for a total value of $12,710,065.76. Following the transaction, the chief executive officer now owns 165,273 shares in the company, valued at approximately $18,267,624.69. This trade represents a 41.03 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 2.00% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. LRI Investments LLC lifted its holdings in shares of Cooper Companies by 4.5% during the 2nd quarter. LRI Investments LLC now owns 2,595 shares of the medical device company's stock worth $227,000 after acquiring an additional 112 shares during the period. Mitchell & Pahl Private Wealth LLC increased its position in shares of Cooper Companies by 1.5% during the 3rd quarter. Mitchell & Pahl Private Wealth LLC now owns 7,986 shares of the medical device company's stock worth $881,000 after purchasing an additional 117 shares in the last quarter. Commonwealth Equity Services LLC lifted its holdings in Cooper Companies by 0.8% during the 2nd quarter. Commonwealth Equity Services LLC now owns 15,600 shares of the medical device company's stock valued at $1,362,000 after purchasing an additional 118 shares during the last quarter. Bleakley Financial Group LLC boosted its position in Cooper Companies by 2.1% in the third quarter. Bleakley Financial Group LLC now owns 5,767 shares of the medical device company's stock valued at $636,000 after buying an additional 119 shares in the last quarter. Finally, First Horizon Advisors Inc. grew its stake in Cooper Companies by 4.8% during the second quarter. First Horizon Advisors Inc. now owns 2,709 shares of the medical device company's stock worth $236,000 after buying an additional 125 shares during the last quarter. Institutional investors own 24.39% of the company's stock.

Cooper Companies Stock Up 0.5 %

COO stock traded up $0.51 during trading hours on Tuesday, hitting $94.49. The company's stock had a trading volume of 1,955,994 shares, compared to its average volume of 1,170,315. The company has a market capitalization of $18.86 billion, a PE ratio of 48.46, a price-to-earnings-growth ratio of 2.52 and a beta of 0.97. The stock has a 50 day moving average price of $103.04 and a two-hundred day moving average price of $99.00. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. Cooper Companies has a 12 month low of $84.76 and a 12 month high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $1.03 billion. During the same quarter in the prior year, the business earned $0.87 earnings per share. The company's revenue was up 9.8% on a year-over-year basis. On average, equities research analysts expect that Cooper Companies will post 3.98 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages recently issued reports on COO. Wells Fargo & Company lifted their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an "overweight" rating in a research note on Friday, December 6th. Piper Sandler upped their target price on shares of Cooper Companies from $115.00 to $120.00 and gave the company an "overweight" rating in a research note on Thursday, August 29th. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a research note on Friday, December 6th. Citigroup cut their price objective on Cooper Companies from $116.00 to $115.00 and set a "buy" rating on the stock in a research note on Friday, December 6th. Finally, Stifel Nicolaus reaffirmed a "buy" rating and set a $115.00 target price (up previously from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Four analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $117.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.